Odylia Therapeutics Inc. Logo

MIP Score

63

Med Research
Eye Research

Odylia Therapeutics Inc.

Mission

Odylia Therapeutics is a nonprofit organization focused on developing therapies for rare diseases that currently have no available treatment. By utilizing a unique nonprofit drug development model, Odylia accelerates drug development timelines, reduces costs, and partners with patient advocates and academic researchers to bring hope to the underserved rare disease patient community.

Basic Information

Tax-Exempt

Address

1447 Peachtree St NE, Atlanta, Georgia, 30309

View all Atlanta charities

Founded in

2017

EIN

82-2120760

Total Assets

$10.02 million

UN Sustainable Development Goals Supported

This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.

At a Glance

Our Gene Therapy Pipeline

Our Gene Therapy Pipeline

Learn about the innovative gene therapies Odylia is developing for rare diseases.

Brydge Solutions

Brydge Solutions

Explore how Brydge Solutions is helping accelerate therapeutic efforts for rare diseases.

The Odylia Collective

The Odylia Collective

Discover Odylia's initiatives to empower patient groups and research communities.

Our Programs

Gene Therapy Pipeline

A program focused on developing gene therapies for rare diseases that do not have existing treatments.

Learn More

Brydge Solutions

An initiative aimed at helping increase the efficiency and success rates of drug development for rare diseases.

Learn More

Volunteer Opportunities

Regulatory Affairs Support

Assist Odylia with navigating the regulatory landscape for drug development.

Graphic Design and Social Media Engagement

Help enhance Odylia’s outreach through graphic design and social media strategy.

Medical Writing

Contribute to the creation of medical documents and communications for Odylia.

MIP Score (Beta)

The MIP Score is in beta! We'd love any feedback you may have.

The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.

Overall Score

63

70

/100

Program Expense Ratio

77.71%

12

/20

Program Revenue Growth

7.36%

16

/20

Leverage Ratio

0.009555

20

/20

Working Capital Ratio

11.46

20

/20

Fundraising Efficiency

0

2

/20

Latest Filing Data: Form 990

Fiscal Year:2022

Source:Source: Self-reported by organization

Financial Details

Revenue

CategoryAmountPercentage
Contributions, Gifts, and Grants976.5K88.90%
Program Services107.4K9.77%
Investment Income14.56K1.33%
Sales of Non-Inventory Assets00.00%
Other Notable Sources00.00%
Total Revenue1.098M100.00%